118 related articles for article (PubMed ID: 29097910)
1. Analytical Interference by Contrast Agents in Biochemical Assays.
Otnes S; Fogh-Andersen N; Rømsing J; Thomsen HS
Contrast Media Mol Imaging; 2017; 2017():1323802. PubMed ID: 29097910
[TBL] [Abstract][Full Text] [Related]
2. Interference of gadolinium-based contrast agents on colorimetric calcium assays.
Yan R; Tarr H; McNally M; Cartier LJ; Chen Y
Clin Biochem; 2014 May; 47(7-8):648-53. PubMed ID: 24365398
[TBL] [Abstract][Full Text] [Related]
3. The protein and contrast agent-specific influence of pathological plasma-protein concentration levels on contrast-enhanced magnetic resonance imaging.
Goetschi S; Froehlich JM; Chuck NC; Curcio R; Runge VM; Andreisek G; Nanz D; Boss A
Invest Radiol; 2014 Sep; 49(9):608-19. PubMed ID: 24710201
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of iodinated and gadolinium-based contrast agents in renal tubular cells at angiographic concentrations: in vitro study.
Heinrich MC; Kuhlmann MK; Kohlbacher S; Scheer M; Grgic A; Heckmann MB; Uder M
Radiology; 2007 Feb; 242(2):425-34. PubMed ID: 17179401
[TBL] [Abstract][Full Text] [Related]
5. Gadolinium magnetic resonance contrast agents produce analytic interference in multiple serum assays.
Proctor KA; Rao LV; Roberts WL
Am J Clin Pathol; 2004 Feb; 121(2):282-92. PubMed ID: 14983944
[TBL] [Abstract][Full Text] [Related]
6. Intravenous Gadoxetate Disodium Administration Reduces Breath-holding Capacity in the Hepatic Arterial Phase: A Multi-Center Randomized Placebo-controlled Trial.
McClellan TR; Motosugi U; Middleton MS; Allen BC; Jaffe TA; Miller CM; Reeder SB; Sirlin CB; Bashir MR
Radiology; 2017 Feb; 282(2):361-368. PubMed ID: 27509544
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T.
Attenberger UI; Runge VM; Jackson CB; Baumann S; Birkemeier K; Michaely HJ; Schoenberg SO; Reiser MF; Wintersperger BJ
Invest Radiol; 2009 May; 44(5):251-6. PubMed ID: 19550376
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effect of two gadolinium-containing contrast-enhancing agents, gadobutrol and gadoxetate disodium, on colorimetric calcium determinations in serum and plasma.
Löwe A; Breuer J; Palkowitsch P
Invest Radiol; 2011 Jun; 46(6):366-9. PubMed ID: 21285889
[TBL] [Abstract][Full Text] [Related]
9. The impact of the viscosity and osmolality of iodine contrast agents on renal elimination.
Jost G; Pietsch H; Lengsfeld P; Hütter J; Sieber MA
Invest Radiol; 2010 May; 45(5):255-61. PubMed ID: 20375847
[TBL] [Abstract][Full Text] [Related]
10. The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography.
Thomsen HS; Morcos SK; Erley CM; Grazioli L; Bonomo L; Ni Z; Romano L;
Invest Radiol; 2008 Mar; 43(3):170-8. PubMed ID: 18301313
[TBL] [Abstract][Full Text] [Related]
11. Iodixanol 320 results in better renal tolerance and radiodensity than do gadolinium-based contrast media: arteriography in ischemic porcine kidneys.
Elmståhl B; Nyman U; Leander P; Golman K; Chai CM; Grant D; Doughty R; Pehrson R; Björk J; Almén T
Radiology; 2008 Apr; 247(1):88-97. PubMed ID: 18292474
[TBL] [Abstract][Full Text] [Related]
12. Interference of medical contrast media on laboratory testing.
Lippi G; Daves M; Mattiuzzi C
Biochem Med (Zagreb); 2014; 24(1):80-8. PubMed ID: 24627717
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
Gupta RT; Iseman CM; Leyendecker JR; Shyknevsky I; Merkle EM; Taouli B
AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
[TBL] [Abstract][Full Text] [Related]
14. CAIPIRINHA-Dixon-TWIST (CDT)-volume-interpolated breath-hold examination (VIBE) for dynamic liver imaging: comparison of gadoterate meglumine, gadobutrol and gadoxetic acid.
Budjan J; Ong M; Riffel P; Morelli JN; Michaely HJ; Schoenberg SO; Haneder S
Eur J Radiol; 2014 Nov; 83(11):2007-12. PubMed ID: 25172427
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of gadobutrol, a macrocyclic, nonionic gadolinium chelate in a brain glioma model: comparison with gadoterate meglumine and gadopentetate dimeglumine at 1.5 T, combined with an assessment of field strength dependence, specifically 1.5 versus 3 T.
Attenberger UI; Runge VM; Morelli JN; Williams J; Jackson CB; Michaely HJ
J Magn Reson Imaging; 2010 Mar; 31(3):549-55. PubMed ID: 20187196
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic effects of ionic high-osmolar, nonionic monomeric, and nonionic iso-osmolar dimeric iodinated contrast media on renal tubular cells in vitro.
Heinrich MC; Kuhlmann MK; Grgic A; Heckmann M; Kramann B; Uder M
Radiology; 2005 Jun; 235(3):843-9. PubMed ID: 15845795
[TBL] [Abstract][Full Text] [Related]
17. Influence of radiographic contrast media on the nitric oxide release from human arterial and venous endothelial cells on extracellular matrix.
Franke RP; Fuhrmann R; Jung F
Clin Hemorheol Microcirc; 2013; 55(1):95-100. PubMed ID: 23445626
[TBL] [Abstract][Full Text] [Related]
18. Effects of non-ionic iodinated contrast media on patient heart rate and pressures during intra-cardiac or intra-arterial injection.
Schmid I; Didier D; Pfammatter T; Garachemani A; Fleisch M; Kirchin MA; Meier B
Int J Cardiol; 2007 Jun; 118(3):389-96. PubMed ID: 17376548
[TBL] [Abstract][Full Text] [Related]
19. Cerebral neoplastic enhancing lesions: multicenter, randomized, crossover intraindividual comparison between gadobutrol (1.0M) and gadoterate meglumine (0.5M) at 0.1 mmol Gd/kg body weight in a clinical setting.
Anzalone N; Scarabino T; Venturi C; Cristaudo C; Tartaro A; Scotti G; Zimatore D; Floris R; Carriero A; Longo M; Cirillo M; Cova MA; Gatti S; Voth M; Colosimo C
Eur J Radiol; 2013 Jan; 82(1):139-45. PubMed ID: 21890295
[TBL] [Abstract][Full Text] [Related]
20. Transient Severe Motion Artifact Related to Gadoxetate Disodium-Enhanced Liver MRI: Frequency and Risk Evaluation at a German Institution.
Well L; Rausch VH; Adam G; Henes FO; Bannas P
Rofo; 2017 Jul; 189(7):651-660. PubMed ID: 28445909
[No Abstract] [Full Text] [Related]
[Next] [New Search]
